Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

fenofibric acid

fenofibric acid
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Trilipix DELAYED RELEASE CAPSULE, ORAL 45 mg, 135 mg    
Fibricor TABLET, ORAL 35 mg, 105 mg    
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

NOTES

fenofibric acid (Trilipix)

  • 45 mg delayed release capsule

fenofibrate (TriCor)

  • 54 mg tablet
  

fenofibric acid (Trilipix)

  • 135 mg delayed release capsule
 fenofibrate (Tricor)
  • 160 mg tablet
  

fenofibric acid (Fibricor)

  • 35 mg tablet
  • 105 mg tablet

fenofibrate (TriCor)

  • 54 mg tablet
  • TWO 54 mg tablets (Total: 108 mg)

 

For FIBRICOR 105 mg, give two 54 mg tabs of generic product.

Trilipix medication guide

Reviewed: February 26, 2009

Last updated: Dec. 21, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved